| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/20/2007 | US20070218003 Truncated Dance, Dance Complex And Method Of Using These |
| 09/20/2007 | DE20321512U1 Zusammensetzung zur Erleichterung der Humangeburt Composition to facilitate human childbirth |
| 09/20/2007 | DE202007007241U1 Krebsprävention an Säugern durch Aktivierung embryonaler Zellen im Verlaufe der ontogenetischen Entwicklung mit Hilfe von Zellwachstumsregulatoren (Auxine) in Kombination mit einem Trägerstoff aus Phospholipiden und Pflanzenölen Cancer prevention in mammals by activation of embryonic cells in the course of ontogenetic development with the help of cell growth regulators (auxins) in combination with a base of phospholipids and vegetable oils |
| 09/20/2007 | CA2644389A1 Pharmaceutical combinations of hcv-protease and -ires inhibitors |
| 09/20/2007 | CA2643167A1 Diagnostic compositions and treatment methods for conditions involving trophoblast cell death, differentiation, invasion and/or cell fusion and turnover |
| 09/20/2007 | CA2640520A1 Extended cycle multiphasic oral contraceptive method |
| 09/19/2007 | EP1834961A2 Design of chemokine analogs for the treatment of human diseases |
| 09/19/2007 | EP1834650A1 Cancer vaccine preparation |
| 09/19/2007 | EP1834644A2 Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
| 09/19/2007 | EP1833570A1 Treatment for severe melancholic depression with epa |
| 09/19/2007 | EP1750765B1 Antimycobacterial pharmaceutical composition comprising an antitubercular drug |
| 09/19/2007 | EP1732524A4 Methods and compositions for treatment of ion imbalances |
| 09/19/2007 | EP1648439A4 Antiglucocorticoid therapy for the prevention of neurological damage in premature infants |
| 09/19/2007 | EP1648422A4 Treatment and preventi0n of cardiovascular events |
| 09/19/2007 | EP1511719B1 Amide derivatives as inhibitors of the enzymatic activity of renin |
| 09/19/2007 | EP1496907B1 Tyrosine kinase inhibitors |
| 09/19/2007 | EP1480976B1 Thiazole derivatives as npy receptor antagonists |
| 09/19/2007 | EP1478773B1 Methods for assessing acute myeloid leukemia |
| 09/19/2007 | EP1471974B1 Tumor necrosis factor combined with interferon in demyelinating diseases |
| 09/19/2007 | EP1453526B1 Pharmaceutical composition for topical treatment of skin disorders and skin wounds |
| 09/19/2007 | EP1439841B1 Androgen receptor modulators and methods of use thereof |
| 09/19/2007 | EP1407044B1 Rna interference mediating small rna molecules |
| 09/19/2007 | EP1309590B1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 09/19/2007 | EP1263803B1 Embolic compositions |
| 09/19/2007 | EP1242110B1 Composition for treating prostate cancer |
| 09/19/2007 | EP1141003B1 Methods of activation of SGK by phosphorylation. |
| 09/19/2007 | CN101039697A Preventive and/or therapeutic agent for diabetes |
| 09/19/2007 | CN101039696A Methods of healing wounds by administering human il-18 |
| 09/19/2007 | CN101039695A Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes |
| 09/19/2007 | CN101039670A Combinations of nicotinic acetylcholine alpha 7 receptor agonists |
| 09/19/2007 | CN101039665A Composition containing omega-3 fatty acids and omega-6 fatty acids |
| 09/19/2007 | CN101037438A Compositions useful as inhibitors of GSK-3 |
| 09/19/2007 | CN101036787A The application of medicine composition containing proton pump inhibitor in the novel gastroenteritic compound capsule and the preparation |
| 09/19/2007 | CN101036652A Use of 4-pyridylmethylphthalazines for cancer treatment |
| 09/19/2007 | CN100338086C Immunostimulatory nucleic acid molecules |
| 09/19/2007 | CN100338073C Substituted phenylacetic acids |
| 09/19/2007 | CN100338062C Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 09/19/2007 | CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors |
| 09/19/2007 | CN100338060C Novel use of substituted aminomethyl chromans |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/19/2007 | CN100338041C Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof |
| 09/18/2007 | US7271311 Mammalian model for diabetes |
| 09/18/2007 | US7271266 Sucha as methyl 2-(benzyloxy)-6-(4-chlorophenyl)-5-(phenyl)pyridine-3-carboxylate; For therapy and prophylaxis of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome, stress, epilepsy |
| 09/18/2007 | US7271261 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2) |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7271152 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor |
| 09/18/2007 | US7271151 administering to effect phosphate metabolism in a patient; Metastatic-tumor Excreted Phosphaturic-Element (MERE) or "phosphatonin"; treating X-linked rickets and tumour osteomalacia for example |
| 09/18/2007 | US7271137 Neutralize biological pathogens; sterilization of medical equipment; food processing equipment; mixture of bleaching activator, base and water |
| 09/18/2007 | US7270999 Clock gene BMAL2 |
| 09/18/2007 | US7270966 for drug screening agents for treatment and/or prevention of cystic fibrosis by receptor binding ligand; genetic engineering |
| 09/18/2007 | US7270833 Use of potassium for production of cardioplegic solution for prevention of stone heart development during acute cardiac ventricular fibrillation in connection with cardiopulmonary resuscitation |
| 09/18/2007 | US7270832 Carriers for administration of active principles such as drugs or nutriments, cosmetic products or plant health products such as herbicides, pesticides, insecticides, fungicides, etc. |
| 09/18/2007 | US7270818 Treating brain disorder by administering a therapeutically effective amount of antisense oligonucleotide; preventing the formation of Alzheimer senile plaques |
| 09/18/2007 | US7270813 Coupling agents for orthopedic biomaterials |
| 09/18/2007 | CA2417106C Piperazine derivatives |
| 09/18/2007 | CA2392473C Bioadhesive drug delivery system |
| 09/18/2007 | CA2304662C Methods for fabricating polymer-based controlled release preparations |
| 09/18/2007 | CA2299586C Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 09/18/2007 | CA2270952C New use for 1,3-propanediol derivatives |
| 09/18/2007 | CA2174133C Use of alpha receptor antagonists for the treatment of chronic muscle pain |
| 09/13/2007 | WO2007103427A2 Medical use of bilirubin and its structural analogues |
| 09/13/2007 | WO2007102608A1 Stabilizer for hydrophobic compounds |
| 09/13/2007 | WO2007102572A1 Inhibitor for cellular aging |
| 09/13/2007 | WO2007102571A1 Therapeutic agent for functional brain disease |
| 09/13/2007 | WO2007102531A1 Pharmaceutical combination |
| 09/13/2007 | WO2007102326A1 Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector |
| 09/13/2007 | WO2007101863A1 Therapeutic combination of a 5ht2 receptor antagonist and of a 5ht2 receptor activator |
| 09/13/2007 | WO2007101357A2 Hair growth agent for the treatment of human keratin fibers, and method for the production thereof |
| 09/13/2007 | WO2007101347A1 Bir domain binding compounds |
| 09/13/2007 | WO2007079977A3 Nutraceutical compositions comprising tripeptides |
| 09/13/2007 | WO2007051007A3 Combination of antihypertensives with cholesterol-lowering agent |
| 09/13/2007 | WO2007036809A3 Novel acetylsalicylic acid formulations |
| 09/13/2007 | WO2006074182A3 Growth factor therapy mobilization of stem cells into the peripheral blood |
| 09/13/2007 | US20070213961 System and Methods for Optimized Drug Delivery and Progression of Diseased and Normal Cells |
| 09/13/2007 | US20070213800 Method and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
| 09/13/2007 | US20070213750 Composite Staple for Completing an Anastomosis |
| 09/13/2007 | US20070213684 Methods and apparatuses for assuring quality and safety of drug administration and medical products and kits |
| 09/13/2007 | US20070213401 Pharmaceutical uses for alpha2delta ligands |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070213304 Use of Aminosalicylates in Diarrhoea-Predominent Irritable Bowel Syndrome |
| 09/13/2007 | US20070213291 Therapeutically useful synthetic oligonucleotides |
| 09/13/2007 | US20070213256 Novel genes and proteins encoded thereby |
| 09/13/2007 | US20070212431 Cream for treatment of skin injured by the sun |
| 09/13/2007 | US20070212406 Homeopathic drug composition and methods of use thereof |
| 09/13/2007 | US20070212405 Dispersion for pulmonary delivery of a bioactive agent |
| 09/13/2007 | US20070212347 Compositions and methods for treating polycystic kidney disease gene |
| 09/13/2007 | US20070212344 Pharmaceutical preparation with RNA as hemostasis cofactor |
| 09/13/2007 | US20070212339 Use Of At Least One Effector Of Glutathione Metabolism Together With Alpha-Lipoic Acid For The Treatment Of Chronically Obstructive Lung Diseases |
| 09/13/2007 | US20070212328 Immunogenic Compositions |
| 09/13/2007 | US20070212325 Insulin Resistance-Improving Agent |
| 09/13/2007 | US20070212302 Preparation and Use of a Stable Formulation of Allosteric Effector Compounds |
| 09/13/2007 | US20070212300 Delivery of compounds with rehydrated blood cells |
| 09/13/2007 | DE202006014513U1 Pharmazeutische Zusammensetzung, insbesondere Antazidum A pharmaceutical composition, in particular antacid |
| 09/13/2007 | DE102006011359A1 Verwendung eines Kokain-Derivats Use of a cocaine derivative |
| 09/13/2007 | DE102006010720A1 Topisches Produkt zur Stimulation des Wachstums von Propionibakterien und seine Verwendung A topical product for stimulating the growth of Propionibacterium acnes, and its use |
| 09/13/2007 | CA2645018A1 Pharmaceutical combination |
| 09/13/2007 | CA2644020A1 Prolongation of survival of an allograft by inhibiting complement activity |
| 09/13/2007 | CA2643337A1 Cancer treatment combining lymphodepleting agent with ctls and cytokines |